Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1297 clinical trials
Efficacy and Tolerability of Erenumab in the Management of Persistent Redness and Flushing in Rosacea

An exploratory open-label study of rosacea patients to study the efficacy and tolerability of erenumab in the prophylactic treatment of persistent redness and flushing attributed to rosacea. Approximately 30 subjects will be included in the study and receive erenumab 140 mg for three months. The study will begin June 2020 …

flushing
headache
erythema
erenumab
erythematotelangiectatic rosacea
  • 0 views
  • 19 Feb, 2024
Role of Oxidative Stress in Ovarian Tissue After CO2-pneumoperitoneum Application-induced I/R

In the proposed study, biomarkers for ischemia/reperfusion-inflicted damage will be evaluated in a biochemical and histopathological perspective in biopsy samples of ovaries from a young patient group in which hysterectomy and bilateral salpingo-oophorectomy will be performed, laparoscopically.

pneumoperitoneum
laparoscopic salpingo-oophorectomy
hysterectomy
cavity
dental caries
  • 0 views
  • 19 Feb, 2024
Education Program for Care Home Staff

And then a quasi-experiment design without random assignment will be conducted to evaluate the effects of this program on care home staff's sense of competence, knowledge, attitudes, and care approach related to dementia care and staff satisfaction with the intervention.

dementia
  • 0 views
  • 19 Feb, 2024
A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab

The purpose of this phase I/Ib study is to determine the safety profile of NIZ985 (new formulation), and if it can be safely combined with Spartalizumab and to determine the appropriate dose and schedule for further study. Moreover, the study will characterize the pharmacokinetic profiles of NIZ985 as a single …

  • 0 views
  • 19 Feb, 2024
The Anti-inflammatory Effects of Hark ny Medicinal Water

It is a cross-over study, so first half of patients will receive medicinal water, the other half will receive tap water treatment, and after 6 months treatments will be repeated, but patients will receive the other type of water.

psoriasis vulgaris
renal disease
psoriasis
skin lesion
arthritis
  • 0 views
  • 19 Feb, 2024
Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer

The purpose of the research is to evaluate whether both chemotherapy and radiotherapy can lead to higher rates of clinical complete response leading to organ preservation in human subjects with cancer. The objective is to learn if this treatment approach may safely be used as an alternative to the standard …

neutrophil count
total mesorectal excision
xelox
folfoxiri
cancer
  • 0 views
  • 19 Feb, 2024
Intraoperative Ultrasound Guided Compared to Stereotactic Navigated Ventriculoperitoneal Shunt Placement

All patients entering the University Hospital of Basel for elective or emergent VPS surgery will be randomized in 1:1 fashion to one of the study groups at admission or the day before the operation.

probe
ventriculoperitoneal shunts
ventriculoperitoneal shunt
  • 0 views
  • 19 Feb, 2024
TDCS to Improve Motivation and Memory in Elderly (TIME)

In order to elucidate the mechanisms behind these changes, effects of stimulation on motivation and network connectivity will be investigated. If indeed memory can be improved by increasing motivation and effort via stimulating MCC, this study will generate new insights into the motivational mechanisms of successful aging.

  • 0 views
  • 19 Feb, 2024
Ketamine Analgesia in Third Molar Surgery

Patients referred for wisdom tooth surgery are asked to participate in the study. For statistical certainty, in total 165 persons will be enrolled to three groups. Two with active drug (different dose) and one placebo. Everyone gets local anesthesia. The completion of the study will be done in four years.

analgesia
local anesthetics
systemic disease
postoperative pain
anesthesia
  • 0 views
  • 19 Feb, 2024
Transcutaneous Stimulation for Neurological Populations

Phases II-IV will each last up to 8 weeks. After the intervention period is complete, the participant will be asked to come for follow-up visits up to 3 months after the intervention phases are completed (Phase V).

gait training
spasticity
cerebral palsy
spinal cord
transcutaneous stimulation
  • 0 views
  • 19 Feb, 2024